Foundation name in banner image


Sarcoma Research Grants Initiative

2017 Schedule

Sarcoma grant applications are reviewed on a rolling basis. Each application is reviewed on its individual scientific merit in as timely a manner as possible. The peer-review process typically takes 2-4 months.

 What We Fund

The Alan B. Slifka Foundation funds a wide range of sarcoma research topics. Examples include, but are not limited, to:

    o    understanding the molecular biology of sarcomas;
    o    exploring molecular targets for new sarcoma therapies;
    o    studying chromosomal translocations, the oncogenes they generate and their                       role in sarcoma development;
    o    translational studies; vaccine studies, monoclonal antibodies and small-                             molecule inhibitors of signal transduction pathways;
    o    the use of nanotechnology in the diagnosis and treatment of sarcomas;
    o    understanding the basis of radiation-induced sarcoma;
    o    modeling of the process of metastases and drug resistance;
    o    exploring differences in the development of sarcomas in children, adolescents,                    young adults and adults;
    o    research directed at the early detection and diagnosis of sarcoma; and
    o   pre-clinical studies leading to an IND.

How to Apply
You must be a 501(c)(3).  The Foundation will award grants only to applicants that are nonprofit organizations as classified under section 501(c)(3) of the Internal Revenue Service Code. Grants for international programs will be made only through U.S.-based or affiliated 501(c)(3) nonprofit organizations.

1.       If you would like to apply for a grant, please send a 1-2 page letter of intent (LOI) only that briefly describes the topic of the research study, the sub-types of sarcoma under investigation, principal investigator(s) and affiliation(s), project timeline and overall project cost to sarcomaLOI@slifkafoundation.org. If the LOI is of interest to us, we will respond by sending you a grant application to complete. Should we request a full proposal, expect to provide us with the following: project abstract; purpose of investigation; research plan, experimental design and analysis; impacts on field; co-investigators (when applicable); relevant NIH biosketches; budget and references. 

 

2.      All grant applications must be submitted electronically and include: (1) Our completed grant application; (2) NIH biosketches of the principal investigator, the co- investigators and the research fellows associated with the proposed study (in PDF format); and (3) Signed letter of publication compliance (see below).


Open Science and Collaboration

The Alan B. Slifka Foundation encourages the principle of open science. Open science is the timely and public dissemination, availability and use of scientific data as well as the sharing of experimental methodology and observations. We award many individual grants and also encourage applications that involve collaboration between investigators in different departments within and among institutions.

 

Award Amounts and Use of Funds
Grant amounts vary but generally do not exceed $50,000 for one year.  Grant duration also varies but generally does not extend beyond two years.  Grants may be used for the development of models; conducting experiments; development of sarcoma tissue registries; and similar activities related to research into the causes, origins, development, metastasis, molecular biology, diagnosis and treatment of sarcoma. Proposals that undertake studies with patients undergoing treatment or who are participating in an investigational study are considered and have been supported.


Co-Submission
Applicants who are considering co-submitting their proposed research to another organization for funding, must, in the detailed description of the study and the budget, clearly indicate the nature of the support being requested both from the Alan B. Slifka Foundation and from the other organization. We will not make a decision about funding prior to the other organizations decision unless we are administering the peer-review process for both organizations. If another organization is conducting a peer-review process, their outcome will help guide our funding determination.